These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4059474)

  • 21. Age and gender effects on the diagnostic power of the DST.
    Ansseau M; Depauw Y; Charles G; Castro P; D'Haenen H; De Vigne JP; Hubain P; Legros JJ; Pelc I; Toscano A
    J Affect Disord; 1987; 12(3):185-91. PubMed ID: 2956303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisol.
    Gerken A; Holsboer F
    Psychoneuroendocrinology; 1986; 11(2):185-94. PubMed ID: 3018821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of weight change on the dexamethasone suppression test in depressed and anorexic patients.
    Schweitzer I; Maguire KP; Tiller JW; Gee AH; Harrison LC; Davies BM
    Br J Psychiatry; 1986 Dec; 149():751-5. PubMed ID: 3790873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of abnormal dexamethasone suppression test in alcoholics abstinent for four weeks.
    Del Porto JA; Monteiro MG; Laranjeira RR; Jorge MR; Masur J
    Biol Psychiatry; 1985 Nov; 20(11):1156-60. PubMed ID: 4052517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dexamethasone suppression test in a general hospital psychiatric setting.
    Warneke LB
    Can J Psychiatry; 1985 Dec; 30(8):614-8. PubMed ID: 4084903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dexamethasone suppression test in depressive, non-depressive and schizoaffective psychosis.
    Coccaro EF; Prudic J; Rothpearl A; Nurnberg HG
    J Affect Disord; 1985 Sep; 9(2):107-13. PubMed ID: 2932482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metyrapone test in affective disorders and schizophrenia.
    Fava GA; Carson SW; Perini GI; Morphy MA; Molnar G; Jusko WJ
    J Affect Disord; 1984 Jun; 6(3-4):241-7. PubMed ID: 6235255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity.
    Lemus CZ; Asnis GM; Halbreich U; Harkavy Friedman JM; Van Praag HM; Rubinson E; Eisenberg J
    J Affect Disord; 1987; 12(3):219-21. PubMed ID: 2956306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonsuppression of cortisol in depression and immune function.
    Syvälahti E; Eskola J; Ruuskanen O; Laine T
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):413-22. PubMed ID: 4070644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the dexamethasone suppression test with DSM-III criteria in psychiatrically hospitalized adolescents.
    Evans DL; Nemeroff CB; Haggerty JJ; Pedersen CA
    Psychoneuroendocrinology; 1987; 12(3):203-9. PubMed ID: 3615749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dexamethasone suppression test and unipolar-bipolar classification of depression].
    Ayuso Gutiérrez JL; García-Camba E; Cabranes JA; Almoguera MI
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1985; 13(1):1-4. PubMed ID: 4025025
    [No Abstract]   [Full Text] [Related]  

  • 32. HPA axis dysregulation in men with hypersexual disorder.
    Chatzittofis A; Arver S; Öberg K; Hallberg J; Nordström P; Jokinen J
    Psychoneuroendocrinology; 2016 Jan; 63():247-53. PubMed ID: 26519779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Learned helplessness: an experimental model of the DST in rats.
    Haracz JL; Minor TR; Wilkins JN; Zimmermann EG
    Biol Psychiatry; 1988 Feb; 23(4):388-96. PubMed ID: 3342268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major depressive episode and low dose dexamethasone suppression test.
    Sarai M; Taniguchi N; Kagomoto T; Kameda H; Uema T; Hishikawa Y
    Folia Psychiatr Neurol Jpn; 1982; 36(2):109-14. PubMed ID: 7129257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dexamethasone suppression test and response to somatic treatment: a review.
    Gitlin MJ; Gerner RH
    J Clin Psychiatry; 1986 Jan; 47(1):16-21. PubMed ID: 3510195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dexamethasone suppression test repeated after a suicide attempt].
    Wilmotte J; Van Wettere JP; Depauw Y; Charles G
    Acta Psychiatr Belg; 1986; 86(3):242-8. PubMed ID: 3751647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired mitogen-induced lymphocyte responses and the hypothalamic-pituitary-adrenal axis in depressive disorders.
    Cosyns P; Maes M; Vandewoude M; Stevens WJ; De Clerck LS; Schotte C
    J Affect Disord; 1989; 16(1):41-8. PubMed ID: 2521650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dexamethasone suppression test in depressed retarded adults: preliminary findings.
    Beckwith BE; Parker L; Pawlarczyk D; Couk DI; Schumacher KS; Yearwood K
    Biol Psychiatry; 1985 Aug; 20(8):825-31. PubMed ID: 4027299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DST in bulimia without endogenous depression.
    Levy AB; Dixon KN
    Biol Psychiatry; 1987 Jun; 22(6):783-6. PubMed ID: 3593818
    [No Abstract]   [Full Text] [Related]  

  • 40. Age and the dexamethasone suppression test: results from a broad unselected patient population.
    Keitner GI; Ryan CE; Kohn R; Miller IW; Norman WH; Brown WA
    Psychiatry Res; 1992 Oct; 44(1):9-20. PubMed ID: 1461951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.